Patents by Inventor Kohei Sonoda

Kohei Sonoda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

Publication number: 20210163608

Abstract: The present invention relates to therapeutic and/or prophylactic agents for ocular inflammatory disease, which comprise an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.

Type: Application

Filed: July 9, 2020

Publication date: June 3, 2021

Applicants: OSAKA UNIVERSITY, KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, CHUGAI SEIYAKU KABUSHIKI KAISHA

Inventors: Nobuyuki OHGURO, Yasuo TANO, Kohei SONODA, Tatsuro ISHIBASHI
THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

Publication number: 20160326255

Abstract: The present invention relates to therapeutic and/or prophylactic agents for ocular inflammatory disease, which comprise an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.

Type: Application

Filed: July 28, 2016

Publication date: November 10, 2016

Applicants: Osaka University, Kyushu University, National University Corporation, Chugai Seiyaku Kabushiki Kaisha

Inventors: Nobuyuki Ohguro, Yasuo Tano, Kohei Sonoda, Tatsuro Ishibashi
THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

Publication number: 20100129355

Abstract: The present invention relates to therapeutic and/or prophylactic agents for ocular inflammatory disease, which comprise an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.

Type: Application

Filed: July 25, 2008

Publication date: May 27, 2010

Inventors: Nobuyuki Ohguro, Yasuo Tano, Ryoko Tano, Kohei Sonoda, Tatsuro Ishibashi

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT

THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT